Concepts (195)
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with RAYNE ROUCE's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that RAYNE ROUCE has written about over time.
Killer Cells, NaturalAntigens, CD19Leukemia, Myeloid, AcuteReceptors, Antigen, T-CellLymphoproliferative DisordersHematopoietic Stem Cell TransplantationHerpesvirus 4, HumanT-LymphocytesPrecursor B-Cell Lymphoblastic Leukemia-LymphomaEpstein-Barr Virus InfectionsLeukemia, Lymphocytic, Chronic, B-CellCell- and Tissue-Based TherapyHematologic NeoplasmsImmunotherapy, AdoptiveLymphomaGenetic TherapyLeukemiaHealth Services Accessibility
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
| Killer Cells, Natural | 4 | 2015 | 2018 | April 2017 |
| Antigens, CD19 | 10 | 2014 | 2024 | January 2020 |
| Leukemia, Myeloid, Acute | 4 | 2017 | 2025 | January 2020 |
| Receptors, Antigen, T-Cell | 15 | 2015 | 2025 | May 2020 |
| Lymphoproliferative Disorders | 3 | 2014 | 2024 | June 2020 |
| Hematopoietic Stem Cell Transplantation | 9 | 2014 | 2025 | June 2020 |
| Herpesvirus 4, Human | 7 | 2014 | 2025 | August 2020 |
| T-Lymphocytes | 23 | 2016 | 2025 | September 2020 |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2015 | 2025 | November 2020 |
| Epstein-Barr Virus Infections | 4 | 2014 | 2025 | December 2020 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2020 | 2021 | June 2021 |
| Cell- and Tissue-Based Therapy | 9 | 2013 | 2025 | July 2021 |
| Hematologic Neoplasms | 4 | 2016 | 2025 | December 2021 |
| Immunotherapy, Adoptive | 28 | 2015 | 2025 | January 2022 |
| Lymphoma | 4 | 2019 | 2025 | June 2022 |
| Genetic Therapy | 4 | 2019 | 2025 | May 2023 |
| Leukemia | 2 | 2023 | 2024 | November 2023 |
| Health Services Accessibility | 7 | 2024 | 2025 | November 2024 |
To return to the timeline,
click here.